There are 2137 resources available
179P - Prognostic impact of body composition (BC) changes during neoadjuvant chemotherapy (NACT) in breast cancer patients (pts)
Presenter: Luisa Carbognin
Session: E-Poster Display
Resources:
Abstract
180P - Development of prognosis prediction model using cytokeratin 19 mRNA copy number of sentinel lymph node metastasis in breast cancer: A multicenter study in Japan
Presenter: daisuke yotsumoto
Session: E-Poster Display
Resources:
Abstract
181P - The use of Ki67 testing and scoring in HR+, HER2- early breast cancer
Presenter: Jacqueline Brown
Session: E-Poster Display
Resources:
Abstract
182P - Identification of a low-risk luminal breast cancer cohort that may not benefit from multi-gene testing
Presenter: Lei Lei
Session: E-Poster Display
Resources:
Abstract
183P - Prognostic value of high mesenchymal-epithelial transition factor gene (MET) expression in patients with estrogen receptor positive (ER+), human epidermal growth factor receptor negative (HER2-) early breast cancer
Presenter: Anna Diana
Session: E-Poster Display
Resources:
Abstract
184P - The prognostic significance of ALDH-1 and SOX9 expression in early breast cancer
Presenter: OLA Harb
Session: E-Poster Display
Resources:
Abstract
185P - Prognosis of T1bN0 breast cancer according to subtype: Korean Breast Cancer Registry Data
Presenter: Young-joon Kang
Session: E-Poster Display
Resources:
Abstract
186P - Oncologists’ agreement on adjuvant therapy recommendations and the need of 21-gene recurrence score assay in HR+/HER2- early breast cancer
Presenter: Maria Castro-Henriques
Session: E-Poster Display
Resources:
Abstract
187P - Impact of oncotype DX on agreement and confidence in adjuvant treatment decision making in breast cancer
Presenter: Luca Licata
Session: E-Poster Display
Resources:
Abstract
188P - Breast cancer risk factors in Iran: A systematic review & meta-analysis
Presenter: Amir Shamshirian
Session: E-Poster Display
Resources:
Abstract